Sethera Therapeutics Completes First Funding Round
January 2, 2025
Sethera has officially completed its first fundraising round, successfully raising $3M in capital. This milestone brings the company closer to revolutionizing peptide therapeutics through its enzymatic transformations.
Recent News
- The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants
- First Patient Enrolled in Merit Medical’s PREEMIE Study
- iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
- Altitude Lab Demo Day
- Steve Pacelli Appointed CEO of Epitel, Inc.
- Sera Prognostics Announces Pricing of $50 Million Public Offering
